Clinical Trial

A Study of Cadonilimab Combined With Chemotherapy in People With Gastric or Gastroesophageal Junction Cancer

Name: A Study of Cadonilimab Combined With Chemotherapy in People With Gastric or Gastroesophageal Junction Cancer — clinical trial record (NCT07631000)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The purpose of this study is to find out whether adding cadonilimab to the usual chemotherapy approach is an effective and safe treatment for participants with locally advanced/resectable gastric cancer or gastroesophageal junction (GEJ) cancer

Trial Details

NCT Number	NCT07631000
Lead Sponsor	Memorial Sloan Kettering Cancer Center
Conditions	Gastric Cancer, Gastroesophageal-junction Cancer
Enrollment	37 participants
Start Date	2026-05-27
Primary Completion	2029-05-27 (estimated)
Study Completion	2029-05-27 (estimated)
Updated on ClinicalTrials.gov	2026-06-05